Skip to main content
. 2021 May 6;12:686874. doi: 10.3389/fphar.2021.686874

TABLE1.

Screening of small molecular inhibitors in KIT-independent GIST62.

Targets Inhibitors Concentrations (μM)
KIT Imatinib 1.0
SRC PP1 5.0
JAK AG490 10
PLCγ △609 1.0
PI3K LY294002 50
MEK U0126 1.0
MTOR Everolimus 1.0
MDM2 Nutlin-3 5.0
26S Proteasome Bortezomib 0.1
HSP90 17-AAG 0.5